Phase 2 Ovarian Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older at the time of signing the consent form.
- People who are in reasonably good general health and able to tolerate chemotherapy, as assessed by a standard medical scoring system (called ECOG performance status 0–1).
- People who have disease that can be measured on scans, according to standard medical criteria (RECIST 1.1 or irRECIST).
- People with a confirmed diagnosis of recurrent ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, with specific tissue types including serous, endometrioid, clear cell, mucinous, or undifferentiated — confirmed through a pathology report from the original tumour.
- People whose cancer has come back either after 6 months or more since their last platinum-based chemotherapy (called platinum-sensitive), or within less than 6 months (called platinum-resistant). Those in the platinum-sensitive group would need to have a medical reason they cannot receive standard platinum-based treatment, such as serious ongoing side effects, a severe allergic reaction to platinum drugs, or a decision not to pursue standard treatment.
- People who are willing to have a tumour biopsy taken within 4 weeks before starting treatment and again after 3 cycles of treatment. In cases where a new biopsy cannot safely or practically be obtained, previously collected (archived) tumour samples may be accepted, but only with approval from the principal investigator.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- No exclusion criteria were listed in the source information provided. (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
progression-free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.